Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
AI-powered RNAi drug discovery company developing hepatic medicines
Tangram Therapeutics is a biotechnology company combining artificial intelligence and RNA interference to discover and develop novel medicines. Its proprietary chemistry platform…
Bicistronic AAV gene therapies for retinal disease
Ikarovec is a near-clinical-stage gene therapy company developing bicistronic AAV-based therapeutics for vision-threatening retinal diseases. Its proprietary platform combines two…
Phase III-ready antimicrobial advancing post-surgical infection prevention
AMR Bio is a clinical-phase biotechnology company advancing XF-73, a Phase III-ready topical antimicrobial using an ultra-rapid antibacterial mechanism to prevent post-surgical…
Targeted oncology combination therapies in biomarker-defined cancer populations
Mosaic Therapeutics is a Cambridge biotech developing targeted combination therapies for cancer. Its proprietary platform integrates genome-scale CRISPR screening, high-throughput…
Anti-inflammatory drugs for neurodegenerative disease
Sitala Bio is a Cambridge-based biotech developing small molecule drugs that target chronic neuroinflammation in conditions such as Parkinson's and Alzheimer's disease. The…
AI-designed aptamer therapeutics for undruggable targets
PentaBind is a TechBio company using generative AI to design aptamers with drug-like properties for targets that are inaccessible to conventional modalities. Its platform combines…
Patient-derived cell models and assays for oncology drug discovery
Dominion Biotech is a Cheshire-based biotechnology company developing patient-derived cell (PDC) models and assays to support oncology drug discovery and development. Working in…
Benchtop single-molecule fluorescence instruments for life science research
Exciting Instruments develops accessible benchtop single-molecule fluorescence spectroscopy instruments and cloud-based analysis software. Its system enables researchers to…
Integrated drug development, formulation and Phase I clinical services
Quotient Sciences is a contract research, development and manufacturing organisation providing integrated drug development services to pharmaceutical and biotech companies. Its…
Pre-clinical platelet function testing for drug discovery and safety
Platelet Services is a contract research organisation specialising in pre-clinical platelet function testing for pharmaceutical and biotechnology clients. The company provides…
Clinical-stage antibody-drug conjugate specialist targeting solid tumours
Pheon Therapeutics is a clinical-stage biotechnology company developing a pipeline of antibody-drug conjugates for the treatment of solid tumours. The company combines monoclonal…
Macrophage-targeting immuno-oncology therapies for solid tumours
Macomics is an immuno-oncology company developing precision medicines that modulate tumour-associated macrophages to enhance immune responses against cancer. Founded by University…